Recent Quarter Total Invested
$508.10 M
Recent Quarter Institutional Ownership Percentage
110.38%
Total Invested of Last Quarter
$1.14 B
Ownership Percentage of Last Quarter
103.93%
EyePoint Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 8.33 M | $72.43 M | 20.77% | 15.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2024 | 5.18 M | $45.03 M | 37.51% | 9.78% |
| BLACKROCK INC. | 08/13/2024 | 3.76 M | $32.75 M | 35.07% | 7.12% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 3.65 M | $31.75 M | 7.68% | 6.90% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 3.59 M | $31.25 M | -24.49% | 6.79% |
| VANGUARD GROUP INC | 08/13/2024 | 2.77 M | $24.14 M | 15.78% | 5.24% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 2.50 M | $21.77 M | 1.48% | 4.73% |
| MORGAN STANLEY | 10/17/2024 | 2.25 M | $19.60 M | 67.85% | 4.26% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 2.07 M | $18.02 M | 29.09% | 3.92% |
| ESSEX WOODLANDS MANAGEMENT, INC. | 08/14/2024 | 1.55 M | $13.50 M | 0.00% | 2.93% |
| CITADEL ADVISORS LLC | 08/14/2024 | 1.35 M | $11.78 M | -1.53% | 2.56% |
| STATE STREET CORP | 08/14/2024 | 1.22 M | $10.61 M | 18.13% | 2.31% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 1.09 M | $9.51 M | 0.00% | 2.07% |
| LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 1.07 M | $9.33 M | 70.41% | 2.03% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.03 M | $8.98 M | 23.99% | 1.95% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2024 | 922,335 | $8.02 M | 100.00% | 1.74% |
| AMERIPRISE FINANCIAL INC | 08/14/2024 | 921,919 | $8.02 M | 36.92% | 1.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 877,790 | $7.64 M | 51.45% | 1.66% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 791,508 | $6.89 M | -5.71% | 1.50% |
| CAPTION MANAGEMENT, LLC | 08/14/2024 | 749,400 | $6.52 M | 807.26% | 1.42% |
| FINEPOINT CAPITAL LP | 08/13/2024 | 707,404 | $6.15 M | 7.74% | 1.34% |
| FIERA CAPITAL CORP | 10/31/2024 | 677,038 | $5.89 M | 0.88% | 1.28% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 640,274 | $5.57 M | 8.59% | 1.21% |
| DEUTSCHE BANK AG\ | 08/14/2024 | 633,519 | $5.51 M | -24.20% | 1.20% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 630,769 | $5.49 M | 100.00% | 1.19% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 600,402 | $5.22 M | 472.41% | 1.13% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 580,716 | $5.05 M | -71.62% | 1.10% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 09/16/2024 | 476,250 | $4.14 M | 842.45% | 0.90% |
| CANDRIAM S.C.A. | 08/05/2024 | 383,000 | $3.33 M | 0.00% | 0.72% |
| WALLEYE CAPITAL LLC | 08/14/2024 | 373,974 | $3.25 M | 100.03% | 0.71% |
| NORTHERN TRUST CORP | 08/14/2024 | 319,998 | $2.78 M | -0.69% | 0.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 296,900 | $2.58 M | -6.16% | 0.56% |
| PFM HEALTH SCIENCES, LP | 08/14/2024 | 292,926 | $2.55 M | 71.43% | 0.55% |
| FEDERATED HERMES, INC. | 08/08/2024 | 290,212 | $2.52 M | -54.88% | 0.55% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 288,035 | $2.51 M | 64.21% | 0.54% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 08/13/2024 | 282,814 | $2.46 M | 0.00% | 0.53% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 269,885 | $2.35 M | 449.92% | 0.51% |
| AXA S.A. | 08/14/2024 | 263,483 | $2.29 M | 0.06% | 0.50% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 251,348 | $2.19 M | 70.02% | 0.48% |
| HAP TRADING, LLC | 08/14/2024 | 245,000 | $25 | 145.00% | 0.46% |
| ORACLE INVESTMENT MANAGEMENT INC | 08/14/2024 | 231,857 | $2.02 M | -49.80% | 0.44% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 204,892 | $1.78 M | 32.61% | 0.39% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 08/14/2024 | 201,332 | $1.75 M | 100.00% | 0.38% |
| UBS GROUP AG | 08/14/2024 | 189,903 | $1.65 M | -58.41% | 0.36% |
| NEW YORK STATE COMMON RETIREMENT FUND | 07/31/2024 | 188,321 | $1.64 M | -5.25% | 0.36% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 176,300 | $1.53 M | 1,446.49% | 0.33% |
| TREXQUANT INVESTMENT LP | 08/13/2024 | 169,305 | $1.47 M | 27.78% | 0.32% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 167,196 | $1.45 M | 6.78% | 0.32% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 152,800 | $1.33 M | 112.52% | 0.29% |
| STATE OF WISCONSIN INVESTMENT BOARD | 08/14/2024 | 139,526 | $1.21 M | 143.14% | 0.26% |
EyePoint Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of EYPT shares?
During the previous two years, 163 institutional investors and hedge funds held shares of EyePoint Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Cormorant Asset Management, LP: 8.33 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 5.18 M
BlackRock Funding, Inc. /DE: 4.16 M
FRANKLIN RESOURCES INC: 4.01 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3.79 M
Essex Woodlands Management, Inc.: 1.55 M
-
What percentage of EyePoint Pharmaceuticals, Inc. stock is owned by institutional investors?
110.38% of EyePoint Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at EYPT ?
Institutional investors have bought a total of 55.65 M shares in the last 24 months. This purchase volume represents approximately $476.88 M in transactions.